Belicario, Bb Girl .
HRN: 21-83-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2022
AMPICILLIN 250MG (VIAL)
08/25/2022
09/01/2022
IV
140 Mg
Q12H
MSAF Thickly, Maternal UTI
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes